The Patent Finder
US

Oligomer-Opioid Agonist Conjugates

US 8,575,196 In force
OverviewFamilyAssignmentsSources & methods

Term ends Mar 12, 2028 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed Apr 4, 2012 as application 13/386,327 · Granted Nov 5, 2013
Base term, 20 years from filing
Today
20 years from filing
2008 2028
Clock starts
Mar 12, 2008
Term ends
Mar 12, 2028
Granted
Nov 5, 2013
base term fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
21
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 12, 2008, when application PCT/US2008/003353, the earliest non-provisional in its chain, was filed (this one was filed Apr 4, 2012); a parent in its chain could not be resolved (the next row)Mar 12, 2028High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMar 12, 2028Medium confidence

This family

Application PCT/US2008/003353PCT application
no patent term
no patent term
US 8,173,666In force
May 2029
May 2029
Application PCT/US2009/005174PCT application
no patent term
no patent term
Application PCT/US2010/042792PCT application
no patent term
no patent term
Application 13/063,919Abandoned
not computed
not computed
US 8,440,687In force
Mar 2028
Mar 2028
US 8,575,196this patent
Mar 2028
Mar 2028
US 8,569,343In force
Mar 2028
Mar 2028
8 of 21 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 17, 2012
Reel 28571, frame 141
Nektar TherapeuticsWells Fargo Bank, National Association, as Collateral AgentGrant of Security Interest
Jun 5, 2013
Reel 30551, frame 266
Riggs-sauthier, Jennifer; Deng, Bo-liang; Riley, Timothy A.Nektar TherapeuticsAssignment of Assignor's Interest
Oct 6, 2015
Reel 36796, frame 562
Nektar TherapeuticsTC Lending, LLC, as Collateral AgentGrant of Security Interest in United States Patents
Oct 14, 2015
Reel 36866, frame 700
Wells Fargo Bank, National Association, as Collateral AgentNektar TherapeuticsRelease of Security Interest Recorded at Reel 28571, Frame 0141
Oct 28, 2019
Reel 50846, frame 940
Inheris Pharmaceuticals, Inc.TC Lending, LLC, as Collateral AgentSecurity Interest
Oct 28, 2019
Reel 50846, frame 461
Nektar TherapeuticsInheris Pharmaceuticals, Inc.Assignment of Assignor's Interest
Nov 15, 2019
Reel 51038, frame 585
Inheris Pharmaceuticals, Inc.Inheris Biopharma, Inc.Change of Name
Apr 17, 2020
Reel 52435, frame 62
TC Lending, LLC, as Collateral AgentInheris Biopharma, Inc.Release of Security Interest
Apr 17, 2020
Reel 53180, frame 9
TC Lending, LLC, as Collateral AgentNektar TherapeuticsRelease of Security Interest
Jan 9, 2023
Reel 62313, frame 501
Inheris Biopharma, Inc.Nektar TherapeuticsAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited